Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Grünenthal Group
Pharma
Grünenthal acquires Valinor Pharma and Movantik for $250M
Grünenthal has continued its expansion splurge, acquiring Valinor Pharma and its lone commercial product Movantik for $250 million.
Kevin Dunleavy
Jul 22, 2024 11:12am
Grünenthal plants in South America will get $87M in upgrades
Jul 17, 2024 2:24pm
Eisai, BeiGene, Shionogi—Fierce Pharma Asia
Dec 2, 2022 10:00am
Kyowa Kirin offloads mature drugs to Grünenthal in Europe
Nov 28, 2022 11:00am
Grünenthal buys up Nebido from Bayer for $500 million
Jul 14, 2022 9:44am
AZ hands European Crestor rights to old customer Grünenthal
Dec 1, 2020 10:50am
